0001140361-16-046816.txt : 20160106
0001140361-16-046816.hdr.sgml : 20160106
20160106102440
ACCESSION NUMBER: 0001140361-16-046816
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160104
FILED AS OF DATE: 20160106
DATE AS OF CHANGE: 20160106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bailey Sue
CENTRAL INDEX KEY: 0001403769
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 161325617
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD, SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
doc1.xml
FORM 4
X0306
4
2016-01-04
0
0001367644
Emergent BioSolutions Inc.
EBS
0001403769
Bailey Sue
400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG
MD
20879
1
0
0
0
Common Stock
2016-01-04
4
M
0
5760
11.67
A
34260
D
Common Stock
2016-01-04
4
S
0
5760
38.97
D
28500
D
Common Stock
2016-01-04
4
M
0
2880
16.13
A
31380
D
Common Stock
2016-01-04
4
S
0
2880
38.77
D
28500
D
Common Stock
2016-01-04
4
M
0
2880
22.02
A
31380
D
Common Stock
2016-01-04
4
S
0
2880
38.46
D
28500
D
Stock Option
11.67
2016-01-04
4
M
0
5760
0
D
2019-05-20
Common Stock
5760
2880
D
Stock Option
16.13
2016-01-04
4
M
0
2880
0
D
2020-05-19
Common Stock
2880
2880
D
Stock Option
22.02
2016-01-04
4
M
0
2880
0
D
2021-05-18
Common Stock
2880
4320
D
Consists of an option granted under the company's stock incentive plan on May 21, 2009.
Consists of an option granted under the company's stock incentive plan on May 20, 2010.
Consists of an option granted under the company's stock incentive plan on May 19, 2011.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.58 to $39.16, inclusive.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.31 to $39.11, inclusive.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.27 to $38.68, inclusive.
The option vested in three equal installments in May 2010, 2011 and 2012.
The option vested in three equal installments in May 2011, 2012 and 2013.
The option vested in three equal installments in May 2012, 2013 and 2014.
/s/ Eric Burt, attorney-in-fact
2016-01-06